颈动脉斑块超声造影增强预测缺血性卒中复发
本研究前瞻性纳入130例近期缺血性卒中伴颈动脉粥样硬化斑块患者,行全氟丁烷微泡超声造影并随访15-27个月。斑块增强者卒中复发风险显著增高(校正HR 38.264),提示斑块增强是复发的独立预测因子,且可改善Essen卒中风险分层的再分类能力。
要点
- 颈动脉斑块超声造影增强提示卒中复发风险显著增高。
- 斑块增强是复发性卒中的独立预测因子。
- 将斑块增强加入Essen评分可改善风险分层。
核心结论
- 颈动脉斑块超声造影增强是缺血性卒中患者卒中复发的显著独立预测因子。
- 将斑块增强加入Essen卒中风险评分可改善风险分层能力。
研究设计与样本
- 前瞻性研究,筛查151例近期缺血性卒中伴颈动脉粥样硬化斑块患者,149例接受颈动脉超声造影,130例完成15-27个月随访或至卒中复发。
- 使用全氟丁烷微泡超声造影评估斑块增强。
- 参考标准为随访期间卒中复发事件。
关键影像表现/征象
- 超声造影显示斑块增强的患者卒中复发风险增加(22/73,30.1%),无增强者为(3/57,5.3%)。
诊断标准与关键数值
- 多变量Cox比例风险模型分析显示,斑块增强预测卒中复发的校正HR为38.264(95%CI 14.975-97.767;P<0.001)。
- 将斑块增强加入Essen评分后,高风险组较低风险组的HR为2.188(95%CI 0.025-3.388),高于单独Essen评分的HR 1.706(95%CI 0.810-9.014)。
- 加入斑块增强后,复发组中有32.0%被适当向上再分类。
临床应用与阅片要点
- 颈动脉超声造影斑块增强可用于识别卒中复发高风险患者。
- 结合Essen评分和斑块增强可改善风险分层,指导临床决策。
局限性
- 单中心前瞻性研究,样本量有限(130例分析)。
- 随访时间15-27个月,可能不足以评估长期复发风险。
- 未报告超声造影评估斑块增强的观察者间一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Patients with a history of ischemic stroke are at risk for a second ischemic stroke. This study aimed to investigate the relationship between carotid plaque enhancement on perfluorobutane microbubble contrast-enhanced ultrasonography (CEUS) and future recurrent stroke, and to determine whether plaque enhancement can contribute to risk assessment for recurrent stroke compared with the Essen Stroke Risk Score (ESRS).
MATERIALS AND METHODS: This prospective study screened 151 patients with recent ischemic stroke and carotid atherosclerotic plaques at our hospital between August 2020 and December 2020. A total of 149 eligible patients underwent carotid CEUS, and 130 patients who were followed up for 15-27 months or until stroke recurrence were analyzed. Plaque enhancement on CEUS was investigated as a possible risk factor for stroke recurrence and as a possible adjunct to ESRS.
RESULTS: During follow-up, 25 patients (19.2%) experienced recurrent stroke. Patients with plaque enhancement on CEUS had an increased risk of stroke recurrence events (22/73, 30.1%) compared to those without plaque enhancement (3/57, 5.3%), with an adjusted hazard ratio (HR) of 38.264 (95% confidence interval [CI]:14.975-97.767; P < 0.001) according to a multivariable Cox proportional hazards model analysis, indicating that the presence of carotid plaque enhancement was a significant independent predictor of recurrent stroke. When plaque enhancement was added to the ESRS, the HR for stroke recurrence in the high-risk group compared to that in the low-risk group (2.188; 95% CI, 0.025-3.388) was greater than that of the ESRS alone (1.706; 95% CI, 0.810-9.014). A net of 32.0% of the recurrence group was reclassified upward appropriately by the addition of plaque enhancement to the ESRS.
CONCLUSION: Carotid plaque enhancement was a significant and independent predictor of stroke recurrence in patients with ischemic stroke. Furthermore, the addition of plaque enhancement improved the risk stratification capability of the ESRS.
引用
- Huang, Cheng, Liu, et al. Value of Intraplaque Neovascularization on Contrast-Enhanced Ultrasonography in Predicting Ischemic Stroke Recurrence in Patients With Carotid Atherosclerotic Plaque. Korean J Radiol. 2023. PMID: 36907591. doi:10.3348/kjr.2022.0977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。